Keyword: Paul Hudon

What the Sanofi saga tells us about the state of France's industrial strategy

By
A Sanofi distribution centre at Val-de-Reuil in Normandy. © Joel Saget/ AFP A Sanofi distribution centre at Val-de-Reuil in Normandy. © Joel Saget/ AFP

The French pharmaceuticals firm Sanofi has been in the headlines recently because of its setbacks in producing a vaccine against Covid-19, which will not now be ready until the end of 2021 at the earliest. Yet the group has nonetheless decided to go ahead with its restructuring plans and will be trimming back on its research while also moving many of its production plants into a separate company to be sold off. France is now paying the price for having abandoned its industrial and research strategies over the last thirty years. Martine Orange investigates.